These results were similar to those of research conducted in western countries with a higher prevalence of hepatitis C compared to hepatitis B, wherein AFP elevation above cut-off occurred only in 10–43% patients [32–34]. The gene discussed is AFP; the disease is hepatitis B virus infection.